Unknown

Dataset Information

0

Comparing the Diagnostic Accuracy of Clinician Judgment to a Novel Host Response Diagnostic for Acute Respiratory Illness.


ABSTRACT:

Background

Difficulty discriminating bacterial from viral infections drives antibacterial misuse. Host gene expression tests discriminate bacterial and viral etiologies, but their clinical utility has not been evaluated.

Methods

Host gene expression and procalcitonin levels were measured in 582 emergency department participants with suspected infection. We also recorded clinician diagnosis and clinician-recommended treatment. These 4 diagnostic strategies were compared with clinical adjudication as the reference. To estimate the clinical impact of host gene expression, we calculated the change in overall Net Benefit (∆NB; the difference in Net Benefit comparing 1 diagnostic strategy with a reference) across a range of prevalence estimates while factoring in the clinical significance of false-positive and -negative errors.

Results

Gene expression correctly classified bacterial, viral, or noninfectious illness in 74.1% of subjects, similar to the other strategies. Clinical diagnosis and clinician-recommended treatment revealed a bias toward overdiagnosis of bacterial infection resulting in high sensitivity (92.6% and 94.5%, respectively) but poor specificity (67.2% and 58.8%, respectively), resulting in a 33.3% rate of inappropriate antibacterial use. Gene expression offered a more balanced sensitivity (79.0%) and specificity (80.7%), which corresponded to a statistically significant improvement in average weighted accuracy (79.9% vs 71.5% for procalcitonin and 76.3% for clinician-recommended treatment; P<.0001 for both). Consequently, host gene expression had greater Net Benefit in diagnosing bacterial infection than clinician-recommended treatment (∆NB=6.4%) and procalcitonin (∆NB=17.4%).

Conclusions

Host gene expression-based tests to distinguish bacterial and viral infection can facilitate appropriate treatment, improving patient outcomes and mitigating the antibacterial resistance crisis.

SUBMITTER: Jaffe IS 

PROVIDER: S-EPMC8651161 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7928547 | biostudies-literature
| S-EPMC4905578 | biostudies-literature
| S-EPMC4454557 | biostudies-literature
2021-04-06 | GSE168254 | GEO
| S-EPMC7173118 | biostudies-literature
| S-EPMC7440969 | biostudies-literature
2013-08-02 | E-GEOD-46171 | biostudies-arrayexpress
2013-08-02 | GSE46171 | GEO
| S-EPMC6298190 | biostudies-literature
| S-EPMC7000513 | biostudies-literature